OBJECTIVE: The objective of this study was to evaluate the association between axillary web syndrome and the development of lymphoedema after 10 years of follow-up. METHODOLOGY: A prospective observational study in a hospital cohort of women diagnosed with breast cancer and treated at a referral centre for cancer. Patients were followed according to the routine of the hospital's physical therapy service. In addition, a review of medical records was conducted for the period between 5 and 10 years of follow-up. Data on patient characteristics, treatment, tumour and postoperative complications were collected. RESULTS: In all, 964 patients were included, mostly <65 years old (75 %) and classified as being overweight (68 %). Disease was diagnosed as being up to stage IIA in 54.9 % of the cases; 65.1% underwent mastectomy and 83.8% had total axillary dissection. As adjuvant treatment, 61 % underwent chemotherapy, 63.5 % radiotherapy and 68 % hormone therapy. Among surgical complications, 62.6 % of patients had seroma, 40.7 % had necrosis, 35.9 % axillary web syndrome and 31.4 % lymphoedema. There was no association between axillary web syndrome and the development of lymphoedema (OR = 0.87, 95 % CI 0.65 to 1.15, p = 0.329). CONCLUSION: The occurrence of axillary web syndrome was not a risk factor for lymphoedema after 10 years of follow-up.
OBJECTIVE: The objective of this study was to evaluate the association between axillary web syndrome and the development of lymphoedema after 10 years of follow-up. METHODOLOGY: A prospective observational study in a hospital cohort of women diagnosed with breast cancer and treated at a referral centre for cancer. Patients were followed according to the routine of the hospital's physical therapy service. In addition, a review of medical records was conducted for the period between 5 and 10 years of follow-up. Data on patient characteristics, treatment, tumour and postoperative complications were collected. RESULTS: In all, 964 patients were included, mostly <65 years old (75 %) and classified as being overweight (68 %). Disease was diagnosed as being up to stage IIA in 54.9 % of the cases; 65.1% underwent mastectomy and 83.8% had total axillary dissection. As adjuvant treatment, 61 % underwent chemotherapy, 63.5 % radiotherapy and 68 % hormone therapy. Among surgical complications, 62.6 % of patients had seroma, 40.7 % had necrosis, 35.9 % axillary web syndrome and 31.4 % lymphoedema. There was no association between axillary web syndrome and the development of lymphoedema (OR = 0.87, 95 % CI 0.65 to 1.15, p = 0.329). CONCLUSION: The occurrence of axillary web syndrome was not a risk factor for lymphoedema after 10 years of follow-up.
Entities:
Keywords:
Axillary web syndrome; Breast cancer; Lymphoedema; Treatment
Authors: Priscila Bernardina M Soares; Sidinei Quirino Filho; William Pereira de Souza; Renata Cristina R Gonçalves; Daniella Reis B Martelli; Marise Fagundes Silveira; Hercílio Martelli Journal: Rev Bras Epidemiol Date: 2012-09
Authors: Daniella M F Paiva; Vivian O Rodrigues; Marcelle G Cesca; Pamella V Palma; Isabel C G Leite Journal: BMC Womens Health Date: 2013-02-13 Impact factor: 2.809
Authors: Cheryl L Brunelle; Sacha A Roberts; Amy M Shui; Tessa C Gillespie; Kayla M Daniell; George E Naoum; Alphonse Taghian Journal: J Surg Oncol Date: 2020-06-04 Impact factor: 3.454
Authors: Anke Bergmann; Jaqueline Munaretto Timm Baiocchi; Luiz Claudio Santos Thuler Journal: Support Care Cancer Date: 2020-06-09 Impact factor: 3.603
Authors: F Baggi; Luiz Felipe Nevola Teixeira; S Gandini; M C Simoncini; E Bonacossa; F Sandrin; M Sciotto Marotta; G Lanni; P Dadda; D Colpani; A Luini Journal: Support Care Cancer Date: 2018-03-05 Impact factor: 3.603